Douglas Elliman signed a five-year lease at Phillip Frost’s 4400 Biscayne Boulevard from its former parent company.

As viral vector technology matures and overcomes current challenges, it is expected to play an increasingly important role in advancing gene therapy, vaccine development, and biotechnology research, ...

Explore how biotech breakthroughs in 2024 have changed lives, bringing real Christmas miracles to patients and offering hope ...

Bank of America Securities analyst Alec Stranahan maintained a Buy rating on Krystal Biotech (KRYS – Research Report) yesterday and set a price ...

SAN SEBASTIAN, Spain, Dec. 4, 2024 /PRNewswire/ -- VIVEbiotech, a leading lentiviral vector Contract Development and Manufacturing Organization (CDMO), today announced a growth equity investment ...

San Sebastian, Gipuzkoa, Spain, December 4, 2024 - VIVEbiotech, a leading lentiviral vector Contract Development and Manufacturing Organization (CDMO), today announced a growth equity investment from ...